nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—SLC2A9—skeletal joint—osteoarthritis	0.401	0.415	CbGeAlD
Losartan—SLC2A9—cartilage tissue—osteoarthritis	0.27	0.279	CbGeAlD
Losartan—ACE—skeletal joint—osteoarthritis	0.114	0.118	CbGeAlD
Losartan—ACE—forelimb—osteoarthritis	0.0862	0.0892	CbGeAlD
Losartan—ACE—hindlimb—osteoarthritis	0.0775	0.0803	CbGeAlD
Losartan—AGTR1—tendon—osteoarthritis	0.0177	0.0183	CbGeAlD
Losartan—UGT2B17—Phase II conjugation—GSTO1—osteoarthritis	0.00273	0.0799	CbGpPWpGaD
Losartan—UGT2B17—Biological oxidations—GSTO1—osteoarthritis	0.0016	0.0467	CbGpPWpGaD
Losartan—UGT2B17—Metapathway biotransformation—GSTO1—osteoarthritis	0.00158	0.0461	CbGpPWpGaD
Losartan—UGT1A10—Metapathway biotransformation—GSTO1—osteoarthritis	0.000973	0.0285	CbGpPWpGaD
Losartan—ACE—ACE Inhibitor Pathway—TGFB1—osteoarthritis	0.000815	0.0239	CbGpPWpGaD
Losartan—CYP1A2—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000688	0.0201	CbGpPWpGaD
Losartan—UGT1A3—Phase II conjugation—GSTO1—osteoarthritis	0.000671	0.0197	CbGpPWpGaD
Losartan—UGT2B7—Phase II conjugation—GSTO1—osteoarthritis	0.000571	0.0167	CbGpPWpGaD
Losartan—CYP2C8—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000545	0.016	CbGpPWpGaD
Losartan—AGTR1—ACE Inhibitor Pathway—TGFB1—osteoarthritis	0.000544	0.0159	CbGpPWpGaD
Losartan—CYP3A4—Tryptophan metabolism—ALDH1A2—osteoarthritis	0.000531	0.0155	CbGpPWpGaD
Losartan—CYP2C19—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000486	0.0142	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—FMOD—osteoarthritis	0.000476	0.0139	CbGpPWpGaD
Losartan—UGT1A1—Phase II conjugation—GSTO1—osteoarthritis	0.000464	0.0136	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—LEP—osteoarthritis	0.000454	0.0133	CbGpPWpGaD
Losartan—CYP2C9—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000444	0.013	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—FN1—osteoarthritis	0.000437	0.0128	CbGpPWpGaD
Losartan—UGT1A3—Biological oxidations—GSTO1—osteoarthritis	0.000393	0.0115	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL1A—osteoarthritis	0.000393	0.0115	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGES—osteoarthritis	0.000388	0.0113	CbGpPWpGaD
Losartan—UGT1A3—Metapathway biotransformation—GSTO1—osteoarthritis	0.000387	0.0113	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGES—osteoarthritis	0.000379	0.0111	CbGpPWpGaD
Losartan—ACE—Peptide hormone metabolism—IGF1—osteoarthritis	0.000375	0.011	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—osteoarthritis	0.00037	0.0108	CbGpPWpGaD
Losartan—UGT2B7—Biological oxidations—GSTO1—osteoarthritis	0.000334	0.00978	CbGpPWpGaD
Losartan—UGT2B7—Metapathway biotransformation—GSTO1—osteoarthritis	0.000329	0.00964	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—ADAMTS13—osteoarthritis	0.000327	0.00958	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—IHH—osteoarthritis	0.000311	0.00909	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—ADAMTS3—osteoarthritis	0.000308	0.00901	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—ADAMTS5—osteoarthritis	0.000308	0.00901	CbGpPWpGaD
Losartan—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.000304	0.00891	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000292	0.00855	CbGpPWpGaD
Losartan—SLC2A9—NRF2 pathway—TGFB1—osteoarthritis	0.000278	0.00813	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—GSTO1—osteoarthritis	0.000273	0.00799	CbGpPWpGaD
Losartan—UGT1A1—Biological oxidations—GSTO1—osteoarthritis	0.000271	0.00794	CbGpPWpGaD
Losartan—UGT1A1—Metapathway biotransformation—GSTO1—osteoarthritis	0.000268	0.00783	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—BGN—osteoarthritis	0.000265	0.00774	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—ADAMTS4—osteoarthritis	0.000262	0.00766	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000227	0.00665	CbGpPWpGaD
Losartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoarthritis	0.000214	0.00627	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—CXCL8—osteoarthritis	0.000213	0.00625	CbGpPWpGaD
Losartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000212	0.00621	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—IL1B—osteoarthritis	0.000205	0.00599	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000202	0.00591	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000202	0.0059	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.000186	0.00546	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—HSPA5—osteoarthritis	0.000186	0.00544	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—HSPA5—osteoarthritis	0.000177	0.00518	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—TIMP1—osteoarthritis	0.000177	0.00518	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—MCF2L—osteoarthritis	0.000175	0.00514	CbGpPWpGaD
Losartan—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.00017	0.00497	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TIMP1—osteoarthritis	0.000169	0.00494	CbGpPWpGaD
Losartan—CYP3A5—Biological oxidations—GSTO1—osteoarthritis	0.000165	0.00483	CbGpPWpGaD
Losartan—CYP3A5—Metapathway biotransformation—GSTO1—osteoarthritis	0.000163	0.00476	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MCF2L—osteoarthritis	0.000159	0.00466	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IHH—osteoarthritis	0.000159	0.00466	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—TGFB1—osteoarthritis	0.000159	0.00466	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000157	0.00459	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—CRP—osteoarthritis	0.000156	0.00457	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—HSPA5—osteoarthritis	0.00015	0.00438	CbGpPWpGaD
Losartan—AGTR1—Allograft Rejection—TNF—osteoarthritis	0.000149	0.00435	CbGpPWpGaD
Losartan—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000147	0.00429	CbGpPWpGaD
Losartan—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.000143	0.00418	CbGpPWpGaD
Losartan—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.000141	0.00413	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000136	0.00397	CbGpPWpGaD
Losartan—CYP2C19—Biological oxidations—GSTO1—osteoarthritis	0.000128	0.00373	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—SMAD3—osteoarthritis	0.000127	0.00373	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—CRP—osteoarthritis	0.000127	0.00372	CbGpPWpGaD
Losartan—CYP2C19—Metapathway biotransformation—GSTO1—osteoarthritis	0.000126	0.00368	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—FMOD—osteoarthritis	0.000117	0.00342	CbGpPWpGaD
Losartan—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000116	0.0034	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL1A—osteoarthritis	0.000115	0.00337	CbGpPWpGaD
Losartan—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000115	0.00336	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000111	0.00324	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—FMOD—osteoarthritis	0.00011	0.00323	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoarthritis	0.000109	0.00319	CbGpPWpGaD
Losartan—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000107	0.00313	CbGpPWpGaD
Losartan—AGTR1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.000106	0.0031	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—CRP—osteoarthritis	0.000101	0.00295	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—FN1—osteoarthritis	0.0001	0.00294	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—FMOD—osteoarthritis	9.95e-05	0.00291	CbGpPWpGaD
Losartan—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	9.94e-05	0.00291	CbGpPWpGaD
Losartan—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	9.8e-05	0.00287	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL1B—osteoarthritis	9.74e-05	0.00285	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—FN1—osteoarthritis	9.57e-05	0.0028	CbGpPWpGaD
Losartan—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	9.54e-05	0.00279	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGES—osteoarthritis	9.53e-05	0.00279	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IHH—osteoarthritis	9.41e-05	0.00276	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MCF2L—osteoarthritis	9.41e-05	0.00276	CbGpPWpGaD
Losartan—UGT1A3—NRF2 pathway—TGFB1—osteoarthritis	9.02e-05	0.00264	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGES—osteoarthritis	8.99e-05	0.00263	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—MMP1—osteoarthritis	8.86e-05	0.00259	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—IGF1—osteoarthritis	8.8e-05	0.00258	CbGpPWpGaD
Losartan—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	8.7e-05	0.00255	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—LEP—osteoarthritis	8.57e-05	0.00251	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoarthritis	8.39e-05	0.00245	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	8.25e-05	0.00241	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGES—osteoarthritis	8.11e-05	0.00237	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—FMOD—osteoarthritis	8.08e-05	0.00237	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	7.95e-05	0.00233	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL1B—osteoarthritis	7.92e-05	0.00232	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	7.85e-05	0.0023	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	7.79e-05	0.00228	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	7.74e-05	0.00227	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	7.67e-05	0.00225	CbGpPWpGaD
Losartan—UGT2B7—NRF2 pathway—TGFB1—osteoarthritis	7.67e-05	0.00224	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—PTGS2—osteoarthritis	7.61e-05	0.00223	CbGpPWpGaD
Losartan—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	7.57e-05	0.00221	CbGpPWpGaD
Losartan—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	7.44e-05	0.00218	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—FMOD—osteoarthritis	7.41e-05	0.00217	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	7.4e-05	0.00216	CbGpPWpGaD
Losartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	7.1e-05	0.00208	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—IGF1—osteoarthritis	7.08e-05	0.00207	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—TNF—osteoarthritis	7.06e-05	0.00207	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.95e-05	0.00203	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—COL9A2—osteoarthritis	6.91e-05	0.00202	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—MMP2—osteoarthritis	6.86e-05	0.00201	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—PTGS2—osteoarthritis	6.76e-05	0.00198	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GSTO1—osteoarthritis	6.72e-05	0.00197	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—COL9A1—osteoarthritis	6.71e-05	0.00196	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGES—osteoarthritis	6.59e-05	0.00193	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—BGN—osteoarthritis	6.51e-05	0.0019	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	6.34e-05	0.00186	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GSTO1—osteoarthritis	6.33e-05	0.00185	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL1B—osteoarthritis	6.29e-05	0.00184	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CXCL8—osteoarthritis	6.27e-05	0.00183	CbGpPWpGaD
Losartan—UGT1A1—NRF2 pathway—TGFB1—osteoarthritis	6.23e-05	0.00182	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—BGN—osteoarthritis	6.13e-05	0.00179	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGES—osteoarthritis	6.04e-05	0.00177	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—IL1B—osteoarthritis	6.01e-05	0.00176	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TNF—osteoarthritis	5.75e-05	0.00168	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	5.75e-05	0.00168	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GSTO1—osteoarthritis	5.71e-05	0.00167	CbGpPWpGaD
Losartan—ALB—Vitamin B12 Metabolism—IL6—osteoarthritis	5.7e-05	0.00167	CbGpPWpGaD
Losartan—ACE—Metabolism of proteins—CXCL8—osteoarthritis	5.7e-05	0.00167	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—BGN—osteoarthritis	5.53e-05	0.00162	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	5.42e-05	0.00159	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—CXCL8—osteoarthritis	5.4e-05	0.00158	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—MMP3—osteoarthritis	5.39e-05	0.00158	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	5.38e-05	0.00158	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	5.37e-05	0.00157	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	5.37e-05	0.00157	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—TGFB1—osteoarthritis	5.28e-05	0.00154	CbGpPWpGaD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoarthritis	5.03e-05	0.00147	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—FMOD—osteoarthritis	4.91e-05	0.00144	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TGFB1—osteoarthritis	4.67e-05	0.00137	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GSTO1—osteoarthritis	4.64e-05	0.00136	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—IL6—osteoarthritis	4.64e-05	0.00136	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—BMP2—osteoarthritis	4.6e-05	0.00135	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—TNF—osteoarthritis	4.57e-05	0.00134	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—BGN—osteoarthritis	4.5e-05	0.00132	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—FN1—osteoarthritis	4.46e-05	0.0013	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	4.44e-05	0.0013	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—TNF—osteoarthritis	4.36e-05	0.00128	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—FMOD—osteoarthritis	4.26e-05	0.00125	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GSTO1—osteoarthritis	4.25e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Hemostasis—HSPA5—osteoarthritis	4.25e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Metabolism—FMOD—osteoarthritis	4.23e-05	0.00124	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—BGN—osteoarthritis	4.12e-05	0.00121	CbGpPWpGaD
Losartan—ALB—Hemostasis—TIMP1—osteoarthritis	4.05e-05	0.00118	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGES—osteoarthritis	4.01e-05	0.00117	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	3.96e-05	0.00116	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	3.9e-05	0.00114	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	3.84e-05	0.00113	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—FMOD—osteoarthritis	3.8e-05	0.00111	CbGpPWpGaD
Losartan—ABCB1—Metabolism—FMOD—osteoarthritis	3.71e-05	0.00109	CbGpPWpGaD
Losartan—ALB—Selenium Micronutrient Network—IL6—osteoarthritis	3.68e-05	0.00108	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGES—osteoarthritis	3.47e-05	0.00102	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—FMOD—osteoarthritis	3.46e-05	0.00101	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGES—osteoarthritis	3.45e-05	0.00101	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	3.19e-05	0.000933	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP3—osteoarthritis	3.19e-05	0.000933	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGES—osteoarthritis	3.1e-05	0.000906	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—CXCL8—osteoarthritis	3.05e-05	0.000894	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGES—osteoarthritis	3.02e-05	0.000885	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—FMOD—osteoarthritis	2.96e-05	0.000866	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SMAD3—osteoarthritis	2.88e-05	0.000844	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGES—osteoarthritis	2.82e-05	0.000826	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GSTO1—osteoarthritis	2.82e-05	0.000826	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—CXCL8—osteoarthritis	2.77e-05	0.000812	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—BGN—osteoarthritis	2.73e-05	0.0008	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.66e-05	0.000778	CbGpPWpGaD
Losartan—ALB—Hemostasis—MMP1—osteoarthritis	2.52e-05	0.000737	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—LEP—osteoarthritis	2.47e-05	0.000721	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GSTO1—osteoarthritis	2.44e-05	0.000715	CbGpPWpGaD
Losartan—ALB—Metabolism—GSTO1—osteoarthritis	2.43e-05	0.000711	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGES—osteoarthritis	2.41e-05	0.000706	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—BGN—osteoarthritis	2.37e-05	0.000693	CbGpPWpGaD
Losartan—ALB—Metabolism—BGN—osteoarthritis	2.35e-05	0.000689	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ESR1—osteoarthritis	2.35e-05	0.000689	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	2.34e-05	0.000685	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—FN1—osteoarthritis	2.32e-05	0.00068	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	2.3e-05	0.000675	CbGpPWpGaD
Losartan—ALB—Hemostasis—FN1—osteoarthritis	2.3e-05	0.000672	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—FMOD—osteoarthritis	2.28e-05	0.000668	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GSTO1—osteoarthritis	2.18e-05	0.000638	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	2.15e-05	0.00063	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GSTO1—osteoarthritis	2.13e-05	0.000623	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—BGN—osteoarthritis	2.11e-05	0.000618	CbGpPWpGaD
Losartan—ABCB1—Metabolism—BGN—osteoarthritis	2.06e-05	0.000604	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF1—osteoarthritis	2.04e-05	0.000596	CbGpPWpGaD
Losartan—ALB—Hemostasis—IGF1—osteoarthritis	2.01e-05	0.000589	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GSTO1—osteoarthritis	1.99e-05	0.000582	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—BGN—osteoarthritis	1.93e-05	0.000564	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PTGS2—osteoarthritis	1.87e-05	0.000547	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGES—osteoarthritis	1.86e-05	0.000545	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PTGS2—osteoarthritis	1.76e-05	0.000516	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GSTO1—osteoarthritis	1.7e-05	0.000497	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BGN—osteoarthritis	1.65e-05	0.000482	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CXCL8—osteoarthritis	1.64e-05	0.000479	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PTGS2—osteoarthritis	1.59e-05	0.000465	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—osteoarthritis	1.56e-05	0.000456	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.53e-05	0.000447	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.52e-05	0.000445	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MMP9—osteoarthritis	1.48e-05	0.000434	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.36e-05	0.000399	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GSTO1—osteoarthritis	1.31e-05	0.000384	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PTGS2—osteoarthritis	1.29e-05	0.000378	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BGN—osteoarthritis	1.27e-05	0.000372	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.24e-05	0.000364	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TGFB1—osteoarthritis	1.22e-05	0.000357	CbGpPWpGaD
Losartan—ALB—Hemostasis—TGFB1—osteoarthritis	1.21e-05	0.000353	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PTGS2—osteoarthritis	1.18e-05	0.000347	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	1.06e-05	0.000311	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—osteoarthritis	9.2e-06	0.000269	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PTGS2—osteoarthritis	7.86e-06	0.00023	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PTGS2—osteoarthritis	6.81e-06	0.000199	CbGpPWpGaD
Losartan—ALB—Metabolism—PTGS2—osteoarthritis	6.77e-06	0.000198	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PTGS2—osteoarthritis	6.07e-06	0.000178	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PTGS2—osteoarthritis	5.93e-06	0.000174	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PTGS2—osteoarthritis	5.54e-06	0.000162	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PTGS2—osteoarthritis	4.73e-06	0.000139	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PTGS2—osteoarthritis	3.65e-06	0.000107	CbGpPWpGaD
